Pharma — India Trademark Cases
240 decisions indexed
Page 6 of 8 · 240 total
Magnolia Ltd. v.Softgel Health Care Pvt. Ltd.
The Bombay High Court granted a temporary injunction favoring Magnolia Ltd. against Softgel Health Care Pvt. Ltd. The court ordered that pending the final disposal of the suit, the defendant is restrained from manufacturing, selling, exporting, or using the disputed trademark 'VAGICLIN Plus' in connection with any pharmaceutical product. This interim order significantly protects the plaintiff's brand rights while the main infringement case proceeds.
Wockhardt Limited v.Torrent Pharmaceuticals Limited
The Supreme Court rejected Wockhardt Limited's appeal against a High Court Division Bench order that had granted an interim injunction based on passing off. The court found that the Division Bench correctly applied the triple test for passing off, establishing reputation and likelihood of confusion due to the minimal difference between the trade names. Despite arguments regarding acquiescence and prior conduct, the Supreme Court held that the balance of convenience favored the original judgment, thereby upholding the protection of Torrent's trademark.
Condore Health Care Pvt.Ltd v.M/S Corem Pharma Pvt Ltd
This case involved a Civil Revision Petition challenging the rejection of a suit filed under the Commercial Courts Act. The petitioner argued that since the estimated value of their intangible trademark rights and reliefs sought was less than one crore rupees, the court lacked jurisdiction. However, the respondent contended that the market value mentioned in the underlying Memorandum of Understanding (MOU) exceeded the threshold. The High Court ultimately ruled that for determining pecuniary jurisdiction under the Act, it is the value of the reliefs estimated by the plaintiff for the purpose of court fees that governs, not the higher market valuation cited elsewhere.
Galderma S.A And Anr v.Medsea Healthcare Pvt Ltd
The Delhi High Court dismissed the defendant's application seeking a summary dismissal of the trademark infringement suit. The court noted that while the plaintiffs had assigned their rights to the mark Q-MED, the timing and effect of this assignment were complex and required full trial evidence. Given the ongoing dispute over ownership changes and alleged concealment, the court ruled that the core issues could not be resolved summarily, allowing the main litigation to proceed.
Torrent Pharmaceuticals Ltd. v.Comed Chemicals Pvt. Ltd.
The Gujarat High Court dismissed Torrent Pharmaceuticals' appeal against a lower court order that vacated an interim injunction. The dispute centered on whether Comed Chemicals' brand name, 'CODROXIL', infringed upon Torrent's registered trademark, 'DROXYL'. Despite arguments regarding phonetic and visual similarity, the court found no prima facie case for confusion, noting that both names originated from the generic drug 'Cefadroxil' and considering the nature of prescription-only pharmaceutical sales. The appeal was dismissed, directing the lower court to finalize the main suit promptly.
Optimus Pharma Pvt Ltd v.Rishabh Lohia & Anr
The Delhi High Court ruled in favor of Optimus Pharma Pvt Ltd in a passing off suit against Rishabh Lohia & Anr. The court found that the defendants dishonestly adopted the trade name 'Optimus' for pharmaceutical products, causing confusion in the market. Consequently, the plaintiff was granted permanent injunctions and awarded punitive damages of ₹3,00,000/- due to the defendant's evasion of court proceedings.
Glaxo Group Limited v.Aar Ess Remedies Private Limited & Ors
The Delhi High Court ruled in favor of Glaxo Group Limited against Aar Ess Remedies Private Limited & Ors for trademark, trade dress, and copyright infringement. The court found that the defendants were infringing on registered trademarks (ZINACEF, FORTAM) and common law rights (FORTAZ), as well as passing off the plaintiff's goods using similar packaging (trade dress/copyright). Given the multiple violations, the court granted permanent injunctions and awarded compensatory and punitive damages of ₹20 lakhs to Glaxo Group.
Ajanta Pharma Ltd v.Uas Pharmaceuticals Pty Ltd & Another
The Calcutta High Court ruled in favor of Ajanta Pharma Ltd in a case involving the trademark 'Sunstop' for sun-screen cream. The court found that Uas Pharmaceuticals Pty Ltd had deliberately attempted to pass off its similar product as belonging to Ajanta, exploiting the plaintiff's established market reputation and substantial sales figures. Consequently, the court granted a decree restraining Defendant No. 1 from continuing this dishonest practice.
Torrent Pharmaceuticals Limited v.Wockhardt Limited And Anr
The Bombay High Court addressed a Notice of Motion concerning an action in passing off brought by Torrent Pharmaceuticals against Wockhardt. The court analyzed the 'classical trinity' of passing off, focusing on misrepresentation and reputation. Ultimately, the judge found that Torrent failed to establish a prima facie case for passing off due to the long co-existence of the rival products without any demonstrated confusion or deception. Consequently, the interim injunction sought by Torrent was dismissed.
Cadila Pharmaceuticals Ltd. v.Medi Pharma & Another
The Delhi High Court ruled in favor of Cadila Pharmaceuticals Ltd. in a trademark infringement suit concerning the brand name 'POLYCAP'. The court granted a permanent injunction, preventing the defendants from manufacturing or marketing products under the disputed mark or any deceptively similar variation. This decision underscores the importance of protecting established pharmaceutical trademarks and maintaining consumer trust regarding product efficacy.
Mankind Pharma Limited v.Sun Pharma Laboratories Limited
Mankind Pharma Limited challenged an order regarding territorial jurisdiction in its trademark infringement suit against Sun Pharma Laboratories Limited. The core dispute centered on whether the plaintiff could file the suit in Chennai, given that the defendant claimed no sales or office presence there. The Madras High Court ultimately dismissed the appeals, finding that the appellant's actions and disclosures indicated a sufficient connection to the local jurisdiction.
M/s. Cavinkaare Private Limited v.Panchaksharam Guru Moorthy
The Madras High Court addressed a complex dispute between M/s. Cavinkaare Private Limited and Panchaksharam Guru Moorthy regarding the trademarks 'KARTHIKA' and 'KARTIKA'. The litigation, which involved claims of infringement and passing off across multiple suits, was ultimately resolved through a Joint Compromise Memo. The court decreed C.S.No.204/2012 based on this compromise, granting Cavinkaare exclusive rights to the trademark in relevant goods and services while dismissing the counter-suit (C.S.No.467/2012).
Pfizer Products, Inc & Anr v.Platinum Pharmaceuticals Pvt Ltd & Ors
The Delhi High Court ruled in favor of Pfizer Products, Inc. in a suit alleging trademark infringement and passing off by Platinum Pharmaceuticals Pvt Ltd. The court found that the defendant was illegally selling a drug under the deceptively similar trademark BEQSULE against the plaintiff's registered mark BECOSULES. Furthermore, the court noted that the defendant adopted an identical trade dress (white and reddish orange color combination) to mislead consumers, leading to a decree of injunction.
Sanofi-Aventis Deutschland GmbH v.Jagdale Industries Private Limited
Sanofi-Aventis challenged the registration of Jagdale Industries' trademark 'CALDALE,' arguing that it was deceptively similar to their own mark 'CARDACE.' The Madras High Court examined the phonetic similarity and potential for consumer confusion, especially given that both products are prescription medicines. Ultimately, the court found no remote possibility or slightest chance of confusion, dismissing Sanofi-Aventis' appeal and upholding the trademark registration.
Sanofi Aventis v.Intas Pharmaceuticals Ltd.
Sanofi Aventis filed a suit against Intas Pharmaceuticals Ltd. alleging trademark infringement and passing off related to blood thinning medicines. The plaintiff sought permission to amend the plaint to reflect significantly increased damages, as the losses mounted over the seven years the suit was pending. The court allowed the amendment, emphasizing that procedural rules should not obstruct the cause of justice, especially when correcting valuation based on evolving market realities.
Cadila Healthcare Limited v.Micro Labs Limited
The Gujarat High Court addressed an appeal concerning a suit filed under Section 142 of the Trademark Act. While addressing procedural matters, the court granted ad-interim relief in favor of the appellant (Cadila Healthcare Limited). This interim order mandates that the respondent (Micro Labs Limited) must provide at least one week's prior written notice before initiating any legal proceedings related to the dispute against the appellant.
M/S Relianc Life Sciences Pvt Ltd v.M/S Reliance Life Sciences & Anr
This Delhi High Court order confirms the settlement reached between M/S Relianc Life Sciences Pvt Ltd and M/S Reliance Life Sciences & Anr. The parties successfully mediated their dispute, leading to a decree that acknowledges the plaintiff's proprietary trademark rights. While the plaintiff agreed to waive damages, the defendants formally acknowledged the validity of the plaintiff's trademarks, resolving the litigation amicably.
Bestochem Formulations(I) Limited v.Mr.Nitin Blaggan & Ors.
In a significant resolution, Bestochem Formulations(I) Limited successfully concluded its dispute against Mr. Nitin Blaggan & Ors. by reaching an amicable out-of-court settlement. The Delhi High Court decreed the suit based on this agreement, which confirmed that Bestochem is the rightful owner of the trademark 'FLUWEL' for pharmaceutical preparations. In exchange for this confirmation, the plaintiff agreed to forgo claims for damages and costs, bringing a long-pending infringement case to a definitive close.
Parul Homoeo Laboratory Pvt. Ltd. v.Royal Group
Parul Homoeo Laboratory Pvt. Ltd. filed a suit for permanent injunction and passing off against Royal Group regarding the use of similar trade marks ('HAEMOFORTE' vs 'HAEMO FORTE') in pharmaceutical preparations. The plaintiff claimed prior user rights, but the defendant challenged the court's territorial jurisdiction, arguing that its operations were based outside Delhi. The Court ultimately found that since neither party had a presence or cause of action arising within Delhi, it lacked the necessary jurisdiction to proceed with the suit.
Medical Technologies Limited v.M/S Neon Laboratories Limited
The Gujarat High Court addressed Letters Patent Appeals concerning interim orders related to a trademark registration dispute. While not delving into the merits of the infringement claim, the court granted the appellant (Medical Technologies Limited) liberty to approach the Single Judge to seek an early hearing and suitable modification of the existing interim orders. This decision allowed the parties to pursue their claims without being unduly influenced by the appellate ruling.
Sun Pharmaceuticals Industries Ltd v.Midley Pharmaceuticals Limied
This Calcutta High Court case involves a passing-off dispute between Sun Pharmaceuticals and Midley Pharmaceuticals concerning the trademarks CARDIVAS and CARVAS. The court framed ten detailed issues, focusing on whether the plaintiff is the proprietor of CARDIVAS, whether the defendant's mark CARVAS is confusingly similar or an imitation, and ultimately, whether the defendant is engaging in passing off. The case was fixed for settlement of these complex trademark infringement claims.
Baroda Pharma Pvt. Ltd. v.Torrent Pharmaceuticals Ltd.
The Gujarat High Court addressed an appeal challenging a lower court's decision to dismiss a notice of motion seeking perpetual injunction against trademark infringement. The suit involved the trademarks 'VAL' and 'VALZ'. The High Court upheld the trial judge’s finding that there was no sufficient basis for immediate injunctive relief, noting differences in pronunciation, structure, and packaging between the two marks. Furthermore, the court emphasized the limited scope of appellate review over discretionary interim orders, directing the trial court to expedite the final hearing on merits.
Dolphin Laboratories P. Ltd. v.Deputy Registrar Of Trademark
The Calcutta High Court addressed an appeal filed by Dolphin Laboratories P. Ltd. against the Deputy Registrar of Trademark. The petitioner argued that the appeal should be transferred to the Intellectual Property Appellate Board (IPAB) due to amendments made to the Trade Mark Act, 1999. Consequently, the court recorded the disposal of TMA No. 2195 of 1995.
M/S Universal Pharma v.G M Bell Health Care Pvt Ltd
The Gujarat High Court dismissed an appeal filed by M/S Universal Pharma against a trial court's interim injunction. The dispute involved allegations of copyright infringement and passing off related to pharmaceutical products. The court found that since the main suit was yet to be decided, scrutinizing evidence at the interim stage would prejudice the trial. Consequently, the High Court vacated the existing injunction, favoring the defendant (Universal Pharma) for now.
G.M.Bell Health Care Pvt.Ltd v.Universal Skin Impex Pvt Ltd
The Gujarat High Court upheld the trial court's decision granting an interim injunction in favor of G.M.Bell Health Care Pvt.Ltd against Universal Skin Impex Pvt Ltd. The dispute centered on the use of product names and trademarks for various medicines, where the appellant claimed ownership via a 2005 assignment deed. The court found no illegality in the trial court's order, allowing the plaintiff to continue restraining infringement while noting that the final decision remains subject to pending litigation before the Bombay High Court.
Mr Pramod Hegde (M/S Meditek India) v.M/S Indchemie Health Specialities Pvt. Ltd.
The Karnataka High Court dismissed a writ petition challenging the Intellectual Property Appellate Board's decision to deny trademark registration. The dispute centered on whether 'Z-CAL' (Petitioner) was deceptively similar to 'ZECAL' (Respondent). Applying established tests for deceptive similarity, the court found that despite minor spelling differences, the marks were phonetically and visually similar, especially within the pharmaceutical industry where buyers rely heavily on pronunciation. Consequently, the court upheld the prior user's rights, preventing the registration of the petitioner's mark.
Unimed Technologies Ltd. v.M/s Eyekare Kilitch Ltd.
The Madras High Court dismissed Original Side Appeals filed by Unimed Technologies Ltd. and Sun Pharmaceutical Industries Limited against a prior order dismissing their injunction application. The court found that the mark 'TOBA', being derived from the generic chemical term Tobramycin, was publici juris. Furthermore, the court noted factual dissimilarities in color schemes and symbols between the products, concluding there was no prima facie case of passing off or consumer confusion, especially since both drugs are sold under prescription by specialized physicians.
Macleods Pharmaceuticals Ltd. v.Procare Laboratories Pvt. Ltd.
The Delhi High Court ruled in favor of Macleods Pharmaceuticals, finding that Procare Laboratories was engaging in passing off by using the name 'Procare' as part of its corporate identity. The court emphasized that for a passing-off action, trademark registration is not essential; rather, prior use and established goodwill are key. Given the defendant's deliberate absence from court proceedings, the court also awarded punitive damages to deter dishonest conduct.
Smithkline Beecham Plc. v.Sunil Sarmalkar
The Delhi High Court dismissed the suit filed by Smithkline Beecham Plc. against Sunil Sarmalkar concerning alleged infringement and passing off of trademarks PARAMAX and PANAMAX, as well as copyright infringement related to a 'Swirl device.' The court emphasized that mere trademark registration is insufficient; the plaintiff must prove actual use and sales to establish distinctiveness and proprietary rights. Furthermore, the court held that the swirl pattern was likely a design element for passing off purposes rather than an original artistic work qualifying for copyright protection.
Merck Kgaa v.Galaxy Hompro And Anr
The Delhi High Court dismissed Merck Kgaa's appeal against the Intellectual Property Appellate Board (IPAB) decision, upholding the registration of the trademark 'RECIBION'. The court found no deceptive similarity between 'CEBION' and 'RECIBION', emphasizing that the common suffix 'BION' is widely used in the pharmaceutical industry. Crucially, the judgment noted the petitioner's lack of recent use of its mark and applied the strict test for confusion, concluding that the marks were sufficiently distinct.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.